Further exploration on OR4D6 revealed that additional BC cell lines were also sensitive to its KD in the context of SRC-3 inhibition, pointing to OR4D6 as a potential anti-cancer therapeutic target and supports the evolving concept that ectopically expressed ORs are hijacked by cancer cells to drive growth factor signaling pathways34. Here, NCOA3 is linked to cancer.